12:00 AM
 | 
Jan 07, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Probuphine buprenorphine regulatory update

Titan said FDA accepted and granted Priority Review to an NDA for Probuphine buprenorphine to treat opioid dependence. The PDUFA date is April 30. Titan is eligible for a $50...

Read the full 128 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >